Browse studies

Find your next paid study

135 recruiting studies matching your filters

Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies

Background: Certain blood cancers can be treated with blood or bone marrow transplants. Sometimes the donor cells attack the recipient's body, called graft-ve…

Hematologic Neoplasms

Estimated

~$500 – $6,750

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT04959175

Phase 2

Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients

To learn if the combination of pirtobrutinib (also called LOXO-305) and venetoclax can help to control mantle cell lymphoma (MCL) that is relapsed (has come ba…

Mantle Cell LymphomaNon Hodgkin LymphomaHematologic Malignancy

Estimated

~$75 – $2,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT05529069

Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study

To collect and analyze specimens that will correlate with clinical outcomes such as acute and late toxicities, quality of life, local control, and survival of …

Solid TumorsHematologic Malignancies

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT02457962

Phase 1

A Phase 1, Open-Label, Multicenter Study of INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

A study to evaluate the safety and tolerability of INCA036873 in participants with advanced solid tumors and hematological malignancies.

Solid TumorsHematologic Malignancies

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Incyte CorporationNCT07195916

Observational

Intervention Strategies to Improve Cognitive Functioning in Hematologic Cancer Survivors After Hematopoietic Cell Transplantation

A pilot study to evaluate feasibility of enrollment of patients in an intervention to improve neurocognitive function in hematopoietic cell transplantation (HC…

Cognitive ImpairmentHematologic NeoplasmsHematopoietic Cell Transplant

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Alabama at BirminghamNCT03094026

A Long-Term Follow-up Study for Subjects Previously Treated With A Century Therapeutics Cellular Therapy Product

This study is designed to collect long-term safety and survival data from participants previously treated in an eligible Century-sponsored index trial. This is…

Hematological MalignancySolid Tumor Malignancy

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Century Therapeutics, Inc.NCT05768269

Phase 2

HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib Following Fludarbine/Melphalan/Total Body Irradiation Conditioning Regimen

Now haplo stem cell transplant using bone marrow or peripheral blood is becoming more feasible with better regimens to prevent graft versus host disease (GVHD)…

Hematological Malignancy

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Henry Ford Health SystemNCT03850366

Phase 2

Optimized CBT for Pts With High-risk Hematologic Malignancies Who Have Relapsed After First ASCT

The goal of this clinical research study is to learn if intermediate-intensity conditioning therapy followed by a cord blood transplant can help to control hig…

Hematologic Malignancies

Estimated

~$75 – $2,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT06807606

Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment

Background: Many advances have been made in cancer treatments, but more research is needed. Comparing samples of cancerous tissue to samples of normal, noncan…

Solid TumorsHematologic MalignancyGastrointestinal Cancer+5 more

Estimated

~$10 – $675

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT05600933

Hematology Biobank: In Vitro Study of Blood Disorders

This is a biorepository of blood specimens from subjects with different Hematological disorders.

Hematological Disorders

Estimated

~$10 – $750

Actual pay is set by the research site.

Albert Einstein College of MedicineNCT02442011

Observational

SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention)

SURGE aims to increase representation in clinical trial enrollment by addressing barriers to genomic testing, which is increasingly needed to assess precision …

Gastrointestinal CancerHematologic CancerThoracic Cancer

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Nadine Jackson, MD, MPHNCT05375643

Observational

DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics

The purpose of this study is to evaluate whether a novel decision support tool called PRIME (Preference Reporting to Improve Management and Experience), which …

Hematologic MalignanciesLymphomaMultiple Myeloma+2 more

Estimated

~$10 – $750

Actual pay is set by the research site.

UNC Lineberger Comprehensive Cancer CenterNCT06296368